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Results of cardiac muscle and skeletal muscle biopsies
were compared in 22 patients with cardiomyopathy; 11
patients presented with symptoms secondary to ventric-
ular tachycardia (Group 1) and 11 had symptoms of
severe congestive heart failure (Group 2). No patient had
structural or ischemic cardiac disease. In Group 1 pa-
tients, hemodynamic abnormalities were subtle, but in-
vasive study demonstrated dilated cardiomyopathy in
two patients and restrictive cardiomyopathy in nine. In
Group 2, eight patients had dilated cardiomyopathy and
three had restrictive cardiomyopathy.
Cardiac biopsy results were abnormal in all 22 pa-
tients and the abnormalities were similar for the two
groups. Cardiac histologic study revealed a spectrum of
abnormalities including fibrosis, dilated sarcoplasmic re-
Histologic abnormalities of cardiac muscle have been pre-
viously demonstrated (1-4) in young patients with conges-
tive heart failure secondary to cardiomyopathy, and similar
findings have been reported (5-7) in young patients pre-
senting with ventricular tachycardia without overt cardiac
disease (so called "primary electrical heart disease" ). In
most cases the histologic abnormalities are similar (7) . Ad-
ditionally, histologic abnormalities of skeletal muscle in
patients with hemodynamic evidence of cardiomyopathy have
been recognized (8,9) and an association between abnormal
skeletal muscle histologic findings and cardiac rhythm dis-
turbances has been previously reported (10).
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ticulum, increased numbers of intercalated discs and
mitochondrial abnormalities. Histologic abnormalities
of skeletal muscle were similar in each group, consisting
ofendomysialfibrosisand increased lipid deposits, Slightly
more than half of the Group 1 and Group 2 patients also
had a low concentration of skeletal muscle long chain
acylcarnitine.
These data demonstrate that abnormalities of both
cardiac and skeletal muscle are common in patients with
cardiomyopathy; abnormalities are similar whether ini-
tial symptoms are due to ventricular tachycardia or
congestive heart failure. It is suggested that these pa-
tients with cardiomyopathy may have a generalized my-
opathy.
(J Am Coli Cardio/ 1987;10:608-18)
The purpose of this study was to compare cardiac and
skeletal musclehistologyand biochemistryin young patients
whose initial manifestations of cardiac disease were due to
symptoms resulting from sustained ventricular tachycardia
or congestive heart failure.
Methods
Study patients. Eleven patients (Group I) with ventric-
ular tachycardia or ventricular fibrillation and II patients
(Group 2) with symptoms of cardiac failure constituted the
study group (Table I) . All patients underwent invasive and
noninvasive cardiac functional evaluation, as well as en-
domyocardial and skeletal muscle biopsy.
Group I consisted of five male and six female patients,
with an average age of 22 years (range IO to 36). Apart
from symptoms induced by ventricular arrhythmia, Group
I patients were in New York Heart Association functional
class I. Symptoms first occurred an average of 16.5 months
0735-1097/87/$3 .50
lACC Vol. 10. NO.3
September 1987:608-18
Table l. Clinical Features of 22 Patients
DUNNIGAN ET AL.
CARDIAC AND SKELETAL MYOPATHY
609
Age (yr) Initial Cardiac Sign or Duration of Symptoms
Case &Sex Symptom Before Evaluation
Group I: Ventricular Arrhythmia
I 28M Palpitation. presyncope 6 Months
2 23M Syncope 2 Months
3 13F Palpitation. presyncope 3 Years
4 32F Palpitation. syncope 1 Year
5 10M Palpitation I Year
6 33F Palpitation 2 Months
7 11M Palpitation I Month
8 18F Syncope 3 Years
9 36F Cardiac arrest I Month
10 19F Syncope. cardiac arrest 5 Years
II 21M Cardiac arrest I Month
Group 2: Congestive Heart Failure
12 31F Dyspnea. fatigue I Month
13 8F Dyspnea. edema 3 Years
14 6F Dyspnea 5 Years
15 IOF Exercise intolerance 14 Months
16 5F Exercise intolerance 16 Months
17 27F Dyspnea 3 Months
18 7F Exercise intolerance I Month
19 39M Dyspnea 3 Months
20 12M Exercise intolerance. chest 6 Months
pain
21 22M Dyspnea I Month
22 14M Exercise intolerance :2 Months
F = female; M = male.
before study. All Group 1 patients had electrocardiographic
(ECG) documentation of ventricular tachycardia (eight pa-
tients) or ventricular fibrillation (three patients) before study.
No patient had identifiable structural congenital heart dis-
ease, ischemic heart disease or neurologic or neuromuscular
abnormalities.
Group 2 consisted of seven female and four male pa-
tients, with an average age of 16 years (range 4 to 39). In
contrast to the Group I patients, the II Group 2 patients
were evaluated because of severe symptoms of congestive
heart failure that had been present for an average of 13
months. These patients were in New York Heart Association
class IV and, as part of their evaluation, were being con-
sidered for cardiac transplantation. Patient 12 had a history
of asthma and Patient 13 had arthrogryposis. No patient had
structural congenital heart disease, ischemic heart disease
or any clinically apparent neuromuscular or neurologic ab-
normalities.
Laboratory assessment of hepatic, renal and thyroid func-
tion was normal in all patients. Complete blood count and
serum electrolytes were also normal.
Clinical observations. A complete history and physical
examination were obtained in each patient. A careful review
of current and recent drug ingestion was performed. Cardiac
evaluation consisted of chest roentgenogram, 12 lead ECG
and M-mode and two-dimensional echocardiogram in all
patients.
Hemodynamic evaluation. All patients underwent
hemodynamic evaluation at cardiac catheterization that con-
sisted of pulmonary artery wedge, pulmonary artery and
intracardiac pressure measurements and oximetry. Addi-
tionally, in 10patients, ventricular compliance was assessed
by repeating hemodynamic measurements after volume
administration (10 cc/kg normal saline solution over 5 min-
utes) (II). Results of these studies were utilized in con-
junction with the echocardiographic evaluation to charac-
terize the type of cardiomyopathy present in each patient,
based on criteria modified from Goodwin (12) and published
normal values ( II ,13,14). Our definitions for classification
of the type of cardiomyopathy present have been delineated
previously (10). In brief, restrictive cardiomyopathy was
definedas normal ventricular size and systolic function, with
elevation of ventricular end-diastolic pressures. Dilated car-
diomyopathv was defined as abnormal ventricular systolic
function with ventricular dilation. Hypertrophic cardio-
myopathy was defined as normal or reduced ventricular size
with normal ventricular systolic function and increased left
ventricular free wall or septal dimension, or both.
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Electrophysiologic evaluation. In addition to ambula-
tory or bedside ECG monitoring, all Group I patients under-
went one or more multicatheter electrophysiologic studies.
Antiarrhythmic drugs were withheld for > 48 hours before
electrophysiologic study. Our previously reported method
of evaluation of patients with documented or suspected ven-
tricular tachycardia was employed for all Group I patients
(10, 15). In brief, three quadripolar electrode catheters were
inserted through the right femoral vein and positioned in
the high rightatrium, His bundle regionand right ventricular
apex. Stimulation was performed from either the high right
atrium or the right ventricular apex using square-wave stim-
uli of 2 ms duration at twice diastolic current threshold from
a custom-made programmable stimulator. Atrioventricular
(AV) and ventriculoatrial conduction was assessed using
standard techniques (1 6).
To initiate ventricular tachycardia, the following pro-
grammed ventricular stimulation protocol was performed:
one to four premature ventricular stimuli were introduced
after an eight beat paced train at 600, 500 and 400 ms, and
ventricular burst pacing at a cycle length of 400 to 220 ms
or to failure of one to one ventricular capture (I5) .
Cardiac muscle evaluation. Right ventricular endo-
myocardial biopsy was performed in all Group I and Group
2 patients. Four to six biopsy specimens were obtained in
each patient. Two or more specimens were inserted into a
buffered formalin solution for analysis by light microscopy
and two or more specimens were placed in 3% phosphate-
buffered glutaraldehyde. Routine light microscopy included
hematoxylin-eosin and Masson trichrome staining. For elec-
tron microscopy, specimens were postfixed in 220 osmium
tetroxide in phosphate buffer, dehydrated in a graded series
of alcohol and embedded. Toluidine blue-stained sections
were evaluated by light microscopy. Thin sections were
stained with uranyl acetate and lead citrate for electron mi-
croscopic examination. Cardiac histologic evaluation was
performed by oneof us (NAS) without knowledgeof specific
clinical data.
Skeletal muscle evaluation. After cardiac catheteriza-
tion, an open skeletal muscle biopsy was obtained in all
Table 2. Cardiac Evaluation of 22 Patient s
Echo Control Pressures (rnm Hg) Pressures After Fluid Challenge
CXR
(mm Hg)
Cl
(CT LVEDD SF RA PAW RA PAW (liters/min EF
Case ratio) (mm) (%) LV PA (mean) (mean) LV PA (mean) (mean) per rrr ' ) (%)
Group I: Ventricular Arrhythmia
0.56 70 20 11 3130 60/36 7 36 2A 30t
2 0.38 54 33 9818 20110 8 98120 24110 5 16
3 0.47 51 27 22/10 ~ II 25115 8 17 3.9
4 0.43 52 30 40/20 6 14 8 18
5 OA I 38 26 100110 22112 7 10 100115 24116 7 II 3.3
6 0.40 48 33 105110 1719 4 8 321 12 3 12
7 OA8 53 34 26114 9 14 32120 II 19
8 0.42 46 28 26112 5 12 32116 8 16
9 0.42 50 35 11 911 2 20110 6 9 133120 29113 6 13 55*
10 0.44 36 39 1817 4 9 2511 7 7 14 3.6
II 0.48 74 22 10018 27112 2 9 3.5 3 1t
Group 2: Congestive Heart Failure
12 0.55 69 17 22/ 14 4 15 2.8 12t
13 0.63 31 40 105130 70/40 16 28 27
14 0.89 57 22 100/20 80150 12 19 3.5 34*
15 0.61 66 18 108122 6 1/29 10 18 23*
16 0.70 53 18 85132 64136 7 26 3. 1
17 0.58 86 13 95130 50125 I I 28 1.3 28t
18 0.68 34 4 1 96140 58134 15 26 3.0 60*
19 0.45 70 14 95/36 40130 10 27 20*
20 0.43 48 27 100112 20/8 I 8 100/25 28/ 16 6 17 3.3
21 0.65 79 10 55/34 18 34 27*
22 0.59 70 14 100128 60/28 5 27 60/32 12 34
*Angiographic ejection fraction; t Multigated blood pool scanejection fraction. CI = cardiac index;CT = cardiothoracic; CXR = chest roentgenogram;
EF = ejection fraction; LV = left ventricle; LVEDD = left ventricular end-diastolic dimension; Echo = echocardiogram; LVEF = left ventricular
ejection fraction; PA = pulmonary artery; PAW = pulmonary artery wedge; RA = right atrium; SF = shortening fraction. Echocardiographic and
hemodynamic measurements were compared with published data from normal subjects (11,13, 14).
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patients. In a manner described previously (10), the biopsy
specimen was divided for the following studies: I) light
microscopy; 2) histochemical analysis; 3) electron micros-
copy; and 4) carnitine assay. The muscle samples for light
microscopic and histochemical analysis were immediately
frozen in liquid methylbutane. Subsequently. the biopsy
samples were subjected to the following standard stains and
reactions (17): hematoxylin-eosin. modified Gornori-tri-
chrome, phosphorylase A, adenosine triphosphatase at pH
9.4 and. after preincubation at pH 4.55 and 4.75. alpha-
glycerol phosphate dehydrogenase. reduced diphosphopyr-
idine nucleotide dehydrogenase, succinic dehydrogenase,
periodic acid-Schiff, oil red 0 and Sudan black. The muscle
samples for electron microscopy were placed immediately
in 5% phosphate-buffered glutaraldehyde and. after standard
preparation, the grids were stained with uranyl acetate and
lead citrate (17). All histologic and histochemical reactions
were reviewed by an observer (S.A.S.) without knowledge
of individual patient clinical data.
Carnitine analysis. Fasting serum free carnitine and
acylcarnitine (short chain and long chain) were measured
by modification of the radioisotopic methods of Pearson et
Table 3. Cardiac Muscle Evaluation
al. (18)and McGarry and Foster (19). as previously reported
(10). In these methods, long chain acylcarnitine is separated
from free carnitine and short chain acylcarnitine by acid
precipitation followed by alkaline extraction. Results were
compared with L-carnitine standard solutions by one of us
(M.E.P.) without knowledge of individual clinical infor-
mation.
The muscle biopsv sample/or carnitine and acvlcarnitine
determination was immediately frozen in liquid nitrogen.
Homogenates were prepared using a Polytron PT-20 (Brink-
man Instruments) to homogenize 5 mg/ml (w/vol) of tissue
in distilled water. Aliquots were removed for measurement
of noncollagenous protein (20). Samples were assayed for
free carnitine, short chain acylcarnitine and long chain acyl-
carnitine as previously described (10).
Results
Echocardiographic andhemodynamic evaluation (Ta-
ble 2). In Group I patients, hemodynamic abnormalities
tended to be subtle and in the majority of patients were
present only after the fluid challenge. Patients I and II were
Case Light Microscopy Electron Microscopy
Group I: Ventricular Arrhythmia
2
3
4
5
6
7
8
9
10
II
Edema. F. fiher size variation
F. vacuoles
F
F
F
F
F
F. vacuoles
F. rnyofibrillar loss
F
F
Myofibrillar loss. dilated SR. myelin whorls
F. increased 10. dilated SR
F. lipid. increased 10: rnyofibrillar loss
Lipid. F
Lipid. increased 11). swollen mitochondria
Lipid. dilated SR. myofibrillar loss. increased lipofuscin
F. increased 10. dilated SR. swollen mitochondria
Myofihrillar loss. increased glycogen. swollen mitochondria,
dilated SR
Myotibrillar loss. dilated SR. lipid. F
Swollen mitochondria. dilated SR
Lipid. F. dilated SR
Group 2: Congestive Heart Failure
12
13
14
15
16
17
18
19
20
21
22
Nuclear proliferation. fiber size
variation. inclusions. F.
vacuoles
Fiber size variation
F
F
Hypotrophy. F
F. vacuoles
F. bizarre cell shape. lipofuscin
F
F. enlarged nuclei
F. myofibrillar loss
F
F. dilated SR. increased 10
F. increased 10
F
F. myelin whorls. Z-hand streaming. myofibrillar loss
F. increased ID
Dilated SR, increased glycogen. increased mitochondria
Abnormal cell junctions. Z-band streaming. increased !D.
myotibrillar loss
F. dilated SR. swollen mitochondria. increased !D. lipid
Hypotrophy. F. dilated SR. sarcomere disarray
Z-band streaming. 10 irregular and tortuous. F
Lipid. dilated SR. prominent rough SR and Golgi apparatus.
swollen mitochondria
F = fibrosis: 10 = intercalated discs: SR = sarcoplasmic reticulum.
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found to have ventriculardilation with decreased ventricular
systolic function, and were therefore classified as having
dilated cardiomyopathy. The remaining Group 1 patients
had normal cardiac chamber size and normal systolic ven-
tricular function, in conjunction with hemodynamic evi-
dence of diastolic dysfunction, and were thereforeclassified
as having restrictive cardiomyopathy. In Group 2, eight
patients had dilated cardiomyopathy, whereas Patients 13,
18 and 20 had restrictive cardiomyopathy. No Group I or
Group 2 patient had hypertrophic cardiomyopathy on echo-
cardiography.
Electrophysiologic characteristics. All Group I pa-
tients had an inducible ventriculararrhythmia that was elec-
trocardiographically similar to that previously documented.
Seven patients had sustained monomorphic ventricular
tachycardia, whereas rapid multimorphic ventricular tachy-
cardia was initiated in the three patients who had experi-
enced a cardiac arrest. Patient 8, who had multimorphic
Figure 1. Patient 3 (Group I). Electron microscopic examination
of right ventricular endomyocardium in a 13 year old girl with
ventricular tachycardia. Cardiac muscle shows an increased num-
ber of lipid droplets within the cytoplasm (L), a focal loss of
myofibrils (*) and rare swollen mitochondria (M). Original mag-
nification x t ,200. reduced by 35%.
ventricular tachycardia documented during a spontaneous
syncopal episode, had a similar tachycardia initiated during
catheter study. Of the seven patients with monomorphic
ventricular tachycardia, the QRS configuration during the
tachycardiawas that of right bundle branch block in Patients
3 and 7, whereas Patients 1, 2 and 4 to 6 had a left bundle
branch block QRS configuration. The cycle length of mono-
morphic ventricular tachycardia ranged from 210 to 300 ms
(mean 254). Initiated monomorphic ventricular tachycardia
was terminated utilizing one to four ventricular extrastimuli
interpolated into the tachycardia. Initiated multimorphic
ventricular tachycardia was terminated with direct current
cardioversion.
Cardiac muscle histologic evaluation (Table 3). Car-
diac muscle histologic features were abnormal in all patients
and the abnormalities were similar in Groups I and 2. In
all Group I patients, fibrosis was observed by light mi-
croscopy. In Patients 2 and 8, vacuoles were seen by light
microscopy and likely represented dilated sarcoplasmic re-
Figure2. Patient 5 (Group I). Electron microscopic examination
of right ventricular endomyocardium in a 10 year old boy with
ventricular tachycardia. Cardiac muscle shows swollen mitochon-
dria (M) and focal separation of the intercalated disc (arrow).
Original magnification x 2.000. reduced by 35%.
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ticulum observed by electron microscopy. Electron micro-
scopic evaluation of the endomyocardial biopsy frequently
demonstrated additional abnormalities withinmyocardial cells,
including increased lipid droplets in six patients, dilated
sarcoplasmic reticulum in seven, mitochondrial abnormal-
ities in four and increased numbers of intercalated discs in
four (Fig. I and 2).
In Group 2, cardiac histologic evaluation demonstrated
abnormalities that were quite similar to those seen in Group
I. Fibrosis was present by light microscopic evaluation in
all II Group 2 patients and Patients 12and 17 had vacuoles
observed by light microscopy that likely represented dilated
sarcoplasmic reticulum observed by electron microscopy.
Additional intracellular electron microscopic abnormalities
included increased numbers of irregular intercalated discs
in six patients, dilated sarcoplasmic reticulum in four pa-
tients, Z-band streaming in three patients and myofibrillar
Figure 3. Patient 18(Group 2). Electron microscopic examination
of right ventricular endomyocardium in a 7 year old girl with
congestive heart failure. Between adjacent muscle cells are com-
plex side to side cell junctions (arrow). The muscle shows rare
areas of Z-line streaming, swollen mitochondria (M) and dilated
sarcoplasmic reticulum. Original magnification x 1,200. reduced
by 35%.
loss in two patients (Fig. 3 and 4). Thus, on the basis of
cardiac biopsy. the two patient groups could not be differ-
entiated.
Skeletalmuscle histologic evaluation (Table4). InGroup
I. skeletal muscle histologic features were normal by light
microscopic and histochemical evaluation in Patients 3, 6
and 8, but were normal on electron microscopic study only
in Patient 6. The principal abnormalities included increased
quantities of lipid in type I muscle fibers (eight patients)
and endomysial fibrosis (eight patients) (Fig. 5 and 6). Non-
specific myopathic features, consisting of type" fiber hy-
potrophy, were seen in Patient 3. By electron microscopy,
Patient 7 also had subsarcolemmal mitochondrial aggre-
gates.
The results of skeletal muscle histologic evaluation were
similar for the Group I and Group 2 patients. In Group 2.
only Patient 15 had normal skeletal muscle by light micro-
Figure 4. Patient 19 (Group 2). Electron microscopic examination
of right ventricular endomyocardium in a 39 year old man with
congestive heart failure. Cardiac tissue shows broad areas of in-
terstitial fibrosis (C), dilated sarcoplasmic reticulum (arrow) and
mitochondrial swelling (M). Original magnification x 1.200. re-
duced by 35c/r .
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Table 4. Skeletal Muscle Evaluation
Case Light Microscopy Histochemistry Electron Microscopy
Group I: Ventricular Arrhythmia
I N N Lipid. EF
2 Lipid. fibrosis N Lipid. EF
3 N Type II hypotrophy EF
4 Lipid N Lipid. EF
5 Lipid N Lipid. EF
6 N N N
7 Lipid N Lipid. subsarcolemmal
mitochondrial aggregates
8 N N EF
9 Lipid N Lipid. EF
10 Lipid N Lipid
II Lipid N Lipid. EF
Group 2: Congestive Heart Failure
12 Lipid Type II hypotrophy Lipid
13 Lipid Type II hypotrophy Lipid. EF. subsarcolemmal
mitochondrial aggregates
14 Lipid N Lipid. EF
15 N N N
16 Lipid Type II hypotrophy. fiber size variation Lipid. EF
17 Lipid Type lIb hypotrophy Lipid. EF
18 Lipid Type lIb hypotrophy Lipid, EF
19 N Type II hypotrophy, moth-eaten type I fiber> Lipid
20 Lipid N Lipid
21 Lipid Type II hypotrophy Lipid
22 Fibrosis Fiber size variation EF
EF 0= endomysial fibrosis: N = normal.
scopic and histochemical evaluation; Patient 15 also had a
normal electron microscopic skeletal muscle evaluation. The
principal skeletal muscle abnormalities in Group 2 patients
were increased quantities of lipid in type I muscle fibers
(nine patients), endomysial fibrosis (six patients) and type
II fiberhypotrophy with or without fibersize variation(eight
patients) (Fig. 7 and 8). Additionally , Patient 13 had var-
iably shaped mitochondria and subsarcolemmal mitochon-
drial aggregates observed by electron microscopy.
Carnitine analysis (Table 5). No abnormalities were
detected in any patient in fasting serum free camitine or
short and long chain acylcamitine concentrations. Skeletal
muscle camitine determinations were also similar for the
two patient groups (Table 5). One patient in each group,
Patients 9 and 16, had a low concentration « 10 nmollmg
of noncollagenous protein)of skeletal musclefree camitine.
However, 7 of 11 Group I patients (Patients 1,2,5,6,9, I0
and II ) and 6 of II Group2 patients (Patients 14,16,17,1 8.19
and 21 ) had a low skeletal muscle concentration of long
chain acylcamitine.
Discussion
Cardiac and skeletal myopathy. The principal findings
of our study are that young patients with cardiomyopathy
who develop either ventricular tachycardia or congestive
heart failure have histologic abnormalities of skeletal and
cardiac muscle; further, cardiac and skeletal muscle histo-
logic features do not permit differentiation of these two
groups of patients. Abnormalities of both cardiac and skel-
etal muscle suggest the presence of a generalized myopathy
in both groups of patients. The cause of the generalized
myopathy is not known. However, the possibility that an
abnormality of muscle metabolism is responsible is sup-
ported by the frequent finding of low concentrationsof long
chain acylcarnitine in skeletal muscle in both groups of
patients.
It is possible that the underlying myopathic process is
similar in both groups of patients and that the clinical man-
ifestation of the disease may be related to factors other than
a specific disease process. For example, Patient I presented
with ventricular tachycardia, but over the ensuing 30 months,
subsequently developed severe congestive heart failure ne-
cessitating cardiac transplantation.-Thus;-i f -patients pre-
senting with rhythmdisturbances as the initial manifestation
of myopathy live long enough, signs and symptoms of poor
mechanicalcardiac function may develop. The converse has
been well recognized in that patients with congestive heart
failure due to dilated cardiomyopathy frequently develop
ventricular tachycardia (21-24). In fact, in some cases these
JACC Vol. 10. NO. 3
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Figure5. Patient 7 (Group I). Sudan blackstainof skeletal muscle
in an II year old boy with ventricular tachycardia. An increased
amount of lipid is present, as evidenced by the heavy black stip-
pled areas. Original magnification X 200, reduced by 350(.
arrhythmias have been recognized to predict or influence
the clinical course of patients with dilated cardiomyopathy.
However. the occurrence of ventricular tachycardia in this
setting has generally been thought to be secondary to the
hemodynamic abnormalities. On the other hand. our patients
with ventricular tachycardia had only subtle findings of
hemodynamic dysfunction, but no clinical symptoms of
congestive heart failure. Thus, in this group of patients
(Group I) it does not seem that the tachycardia is necessarily
secondary to abnormal hemodynamics.
Cardiac muscle abnormalities. Previous reports (1-3)
have described cardiac histologic abnormalities in patients
with cardiomyopathy, including some patients with heart
failure symptoms in whom the diagnosis of myocarditis was
established from the biopsy (3,4,25,26). No patient in our
study had myocarditis or acute round cell cardiac infiltrate.
The young patients with ventricular tachycardia that we
studied all had cardiac histologic abnormalities, and most
had subtle hemodynamic abnormalities as well. It is possible
Figure 6. Patient5 (Group I). Electron microscopic examination
ofskeletal muscle ina 10year old boy with ventricular tachycardia.
Increased lipid (clear vacuoles) and endomysial fibrosi s (arrow)
are present. Original magnification X 13,000, reduced by 35%.
that all patients with ventricular tachycardia have myo-
cardial dysfunction, but that conventional methods for func-
tional evaluation are not sensitive enough to detect abnor-
malities in everyone. From the histologic and biochemical
studies in these ostensibly healthy young patients with ven-
tricular arrhythmias, it is now apparent that the extent of
heart disease is belied by the normalcy of physical and
laboratory evaluation of cardiac status. Thus we question
use of the term ' .primary electrical disease."
A major limitation in several previous reports (5- 7) de-
scribing cardiac biopsy results in patients with rhythm dis-
turbances but without structural heart disease is that they
have been obtained at only one instant in what may be a
progressive disease or a disease subject to exacerbations or
quiescent periods. In contrast. Cassling et al. (27) reported
sequential biopsies in two patients with prebiopsy diagnoses
of myocarditis. One patient appeared to develop interstitial
fibrosis over the 6 week period between biopsies, whereas
in the other patient, initial abnormalities appeared to de-
crease between biopsies. Thus, the natural history of idio-
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Figure 8. Patient 14(Group 2). Electron microscopic examination
of skeletal muscle in a 6 year old girl with congestive heart failure.
Endomysial fibrosis (arrow) is present. Original magnification
x 11,600, reduced by 36%.
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Figure 7. Patient 16 (Group 2). Oil red 0 stain of skeletal muscle
in a 5 year old girl with congestive heart failure. Prominent lipid
staining (stippled areas) is present, as is fiber size variation,
demonstrating type 2 fiber hypotrophy.
pathic cardiomyopathy may be enlightened with serial car-
diac biopsies.
It is important to note that our patients with congestive
heart failure symptoms had myocardial histologic abnor-
malities that were similar to those seen in patients whose
clinical symptoms were secondary to ventricular tachycar-
Table 5. Camitine Analysis Data
Serum Camitine (nmol/rnl) Muscle Camitine (nmol/mg NCP)
FC SCAC LCAC FC SCAC LCAC
Group I: Ventricular Tachycardia
34.2 ± 7.8 6.9 ± 2.0 1.47 ± 0.42 18.46 ± 4.56 2.34 ± 1.68 0.14 ± 0.08
(22.6 to 44.4) (4.2 to 11.1) (0.82 to 2.40) (8.90 to 23.54) (1.04 to 6.83) (0.03 to 0.25)
Group 2: Congestive Heart Failure
43.3 ± 13.8 9.5 ± 4.8 1.70 ± 0.88 19.13 ± 6.94 2.44 ± 0.89 0.22 ± 0.13
(25.1 to 68.9) (5.4 to 19.7) (0.74 to 3.63) (8.96 to 33.86) (1.26 to 4.28) (0.10 to 0.72)
Control Values*
38.5 ± 12.1 5.1 ± 2.0 0.93 ± 0.31 15.85 ± 5.03 2.77 ± 1.01 0.73 ± 0.37
*n = 20 for serum control values, n = 9 for muscle control values; values are mean values ± SO (range).
FC = free camitine; LCAC = long chain acylcarnitine; NCP = noncollagenous protein; SCAC = short chain
acylcamitine.
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dia. The findings of interstitial fibrosis, dilated sarcoplasmic
reticulum, increased numbers of intercalated discs and in-
creased lipid are definitely abnormal, but nonspecific. They
were similar for both groups of patients.
Skeletal muscle abnormalities. Two aspects of the skel-
etal muscle evaluation deserve additional comment. First,
the histologic abnormalities in skeletal muscle were similar
for the patients with ventricular tachycardia and those with
congestive heart failure. Because the patients with tachy-
cardia were completely asymptomatic when the arrhythmia
was absent, skeletal muscle abnormalities were unlikely to
be secondary to cardiac hemodynamic dysfunction. Second,
the findings of skeletal muscle histologic abnormalities and
low concentrations of skeletal muscle long chain acylcar-
nitine in these patients seem more than coincidental. No
patient in our study had systemic camitine deficiency; pa-
tients with carnitine deficiency usually have massive ac-
cumulations of lipid in skeletal muscle (28). Skeletal muscle
histologic abnormalities similar to those found in our pa-
tients have been described in patients with normal or only
mildly decreased skeletal muscle camitine concentrations
(29), and in patients with normal skeletal muscle carnitine
but with carnitine-palmityl-transferase deficiency (30). Thus,
the abnormalities of increased lipid deposition and reduced
long chain acylcamitine concentrations in skeletal muscle
are not specific for a single biochemical or metabolic defect,
but together these findings suggest that a disorder of fatty
acid metabolism is present.
Coexistent cardiac and skeletal myopathy. Few re-
ports (8-10) have linked skeletal muscle histologic abnor-
malities to cardiomyopathy, in which presenting symptoms
are secondary to either cardiac electrical (ventricular tachy-
cardia) or mechanical (congestive heart failure) dysfunction.
In contrast, it is well recognized that patients with various
neuromuscular diseases may also have cardiac muscle in-
volvement (31-37). The clinical manifestations of such in-
volvement may be a result of rhythm disturbances or heart
failure, but generally appear late in the course of disease
after the diagnosis of the peripheral muscle disease is well
established. In contrast to other patients with neuromuscular
disease, the primary clinical manifestation of our patients
involved symptoms secondary to ventricular tachycardia or
congestive heart failure, with the peripheral muscle involve-
ment being subclinical.
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